Data / Form D filings / SEQUOIA PHARMACEUTICALS INC
SEQUOIA PHARMACEUTICALS INC: Form D filing
SEQUOIA PHARMACEUTICALS INC, a pharmaceuticals company in Gaithersburg, MD, filed a Form D with the SEC in 2009. The latest, on June 9, 2009, reports $3.8 million sold of a $5.6 million offering to 7 investors.
Find out what SEQUOIA PHARMACEUTICALS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 401 PROFESSIONAL DRIVE, SUITE 200, Gaithersburg, MD, 20879
- Phone
- (240) 632-0094
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1167157
The full lists. Form D filings in Maryland: 608 rows, $30.40, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 9, 2009 | New notice | $5,600,000 | $3,800,000 | $1,800,000 | 7 | Jun 2, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Denis Lucquin | Director | |
| John Erickson | Director, Executive Officer | |
| Daniel L. Kisner | Director, Executive Officer | |
| Douglas Onsi | Director | |
| Muzammil Mansuri | Director | |
| Steve Skolsky | Director, Executive Officer | |
| David Summa | Director | |
| Linda Peters | Director |
Every Form D from the week of Jun 8, 2009 · All recent filings in Maryland · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what SEQUOIA PHARMACEUTICALS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.